Store Facets Summary
Main page content
Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets
Published: January 2021
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
Treatment Improvement Protocol (TIP) 26: Treating Substance Use Disorder in Older Adults
Published: September 2020
This updated TIP is designed to help providers and others better understand how to identify, manage, and prevent substance misuse in older adults. The TIP describes the unique ways in which the signs and symptoms of substance use disorder (SUD) manifest in older adults; drug and alcohol use disorder screening tools, assessments, and treatments specifically tailored for older clients' needs; the interaction between SUDs and cognitive impairment; and strategies to help providers improve their older clients' social functioning and overall wellness.
TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: May 2020
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Sequential Intercept Model Trifold Brochure
Published: September 2019
This brochure provides an overview of the Sequential Intercept Model (SIM). The SIM is a strategic planning tool that helps communities better understand the gaps and resources they have in helping those with mental illness or substance use disorders who are in the criminal justice system.
Screening and Assessment of Co-Occurring Disorders in the Justice System
Published: June 2019
This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.